Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
2.004
-0.006 (-0.29%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Company Description

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States.

It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants.

It provides medical device products such as the DSU-H and SSU-H which are in-line, 0.005-micron ultrafilters that give dual- and single-stage protection, respectively; S100 which is a point-of-use, 0.01-micron microfilter; and the HydraGuard and HydraGuard - Flush which are 0.005-micron cartridge ultrafilters that given single-stage protection, these products give protection from waterborne pathogens.

Further, it provides the DSU-D, SSU-D, and SSUmini are in-line, 0.005-micron ultrafilters that provide protection from bacteria, viruses, and endotoxins; and the EndoPur, a 0.005-micron cartridge ultrafilter that provides single-stage protection from bacteria, viruses, and endotoxins.

It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions.

The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nephros, Inc.
Nephros logo
Country United States
Founded 1997
IPO Date Sep 21, 2004
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 31
CEO Robert Banks

Contact Details

Address:
380 Lackawanna Place
South Orange, New Jersey 07079
United States
Phone 201 343 5202
Website nephros.com

Stock Details

Ticker Symbol NEPH
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001196298
CUSIP Number 640671400
ISIN Number US6406714005
Employer ID 13-3971809
SIC Code 3841

Key Executives

Name Position
Robert Banks President, Chief Executive Officer and Director
Judy F. Krandel C.F.A. Chief Financial Officer
Brianne McGuire Director of Brand, Marketing and Business Development
Vashone R. Thomas Vice President of Quality, Regulatory, and Human Resources
Greg Lucas President of Aether Water Systems
Judy Mazzini Controller

Latest SEC Filings

Date Type Title
Apr 28, 2025 8-K Current Report
Apr 1, 2025 8-K Current Report
Mar 24, 2025 10-K Annual Report
Mar 6, 2025 8-K Current Report
Mar 4, 2025 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report
Aug 26, 2024 8-K Current Report
Aug 8, 2024 10-Q Quarterly Report
Jun 17, 2024 S-8 Securities to be offered to employees in employee benefit plans